文献速递质量管理与危急值临床血液与体液

基于参考数据的准确性等效评估用于患者数据实时质控模型的临床应用

Accuracy-based equivalence evaluation using reference data for the clinical application of patient-based quality control models.
PubMed 文献 · Clin Chim Acta · 2025-07-09

该研究引入数字计量学与算法溯源概念,以红细胞计数为例建立参考数据集作为数字测量仪器(DMI),通过数字孪生技术构建含测量不确定度的标准化孪生数据,对五种患者数据实时质控(PBRTQC)模型进行准确性等效评估,为实验室选择和部署PBRTQC模型/软件提供依据。

要点

  • 建立参考数据集作为数字测量仪器(DMI)可实现PBRTQC模型的算法溯源与准确性等效评估。
  • 五种PBRTQC模型的算法评估值Y范围为0.638986至0.798970,测量不确定度为(4.1-4.3)×10^-5。
  • 该评估方法可为实验室选择与部署PBRTQC模型/软件提供临床场景下的证据。

核心结论

  • 建立参考数据作为DMI并开展算法溯源,可提供基于准确性的等效评估,为实验室用户选择与部署PBRTQC模型/软件提供证据。

研究设计与样本

  • 以红细胞计数为例建立参考数据集作为数字测量仪器(DMI),每组收集包含九个维度的红细胞计数数据。
  • 通过数字孪生技术开发DMI,由含测量不确定度的标准化孪生数据组成,作为标准评估五种PBRTQC模型。

主要发现

  • 构建了从PBRTQC模型/软件输出结果追溯至DMI、再追溯至仪器原始数据的分层溯源链。
  • DMI包含在控与失控两种状态,对应质控的两种情形。
  • 五种PBRTQC模型的算法评估值Y为0.638986至0.798970,测量不确定度为(4.1-4.3)×10^-5。

关键数值与推荐

  • 五种PBRTQC模型的算法评估值Y范围为0.638986至0.798970。
  • DMI的测量不确定度为(4.1-4.3)×10^-5。

临床怎么用

  • 实验室用户在临床部署PBRTQC模型/软件前,可参考基于DMI的准确性等效评估与算法溯源结果进行选择。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Patient-based real-time quality control (PBRTQC) is an effective quality control (QC) strategy using patient test results to monitor analytical performance. Most studies have proposed different PBRTQC models and tested their performance by developers themselves. However, there remains a need for validating the accuracy-based equivalence of the models/software before clinical application and for periodic review, which is also the requirement of testing and calibration laboratories competence accreditation criteria. To address this issue, we introduce the concept of digital metrology and algorithm traceability into PBRTQC to enable a standardized evaluation. METHODS: A reference data set was established as the digit-measuring instrument (DMI) and applied for metrological traceability, taking red blood cell (RBC) count as an example. RBC count data containing nine dimensions in each group were collected. The DMI was developed through digital twin technology, comprised of standardized twin data with measurement uncertainty (MU), serving as a standard to evaluate five PBRTQC models. RESULTS: A hierarchical traceability chain was constructed, from the PBRTQC models/software output results tracing back to the DMI, and then to the original data generated by the instrument. The DMI included both in-control and out-of-control states, corresponding to the two situations of QC. The algorithm evaluation values Y of the five PBRTQC models were calculated, ranging from 0.638986 to 0.798970, with MU of (4.1-4.3) × 10-5. CONCLUSIONS: Establishing reference data as DMI and conducting algorithm traceability could provide an accuracy-based equivalence evaluation and offer evidence for laboratory users to select and deploy PBRTQC models/software in clinical settings.

来源:Clin Chim Acta,查看原文。版权归原作者所有。

引用

  1. Shang X, Wang T, Zhang M, et al. Accuracy-based equivalence evaluation using reference data for the clinical application of patient-based quality control models. Clin Chim Acta. 2025. PMID: 40645238. doi:10.1016/j.cca.2025.120476

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。